Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 195

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 10
Chunk 195
---
 price on Award  
    Grant Date
    Fair Value of Stock and Option  

    Grant  
    Threshold  
    Target  
    Maximum  
    Threshold  
    Target  
    Maximum  
    or
    Units  
    Options  
    Awards  
    date  
    Awards 
  
    Name 
    Date(1)  
    ($)  
    ($)  
    ($)  
    (#)  
    (#)  
    (#)  
    (#)  
    (#)  
    ($/Sh)  
    ($/Sh)  

    Erez Aminov, CEO 
     8/27/2024  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     1,960,170(2) 
    $5.02(4) 
    $5.26  
    $7,513,332 
  
    Michelle Yanez, CFO 
     8/27/2024  
     -  
        
     -  
     -  
     -  
     -  
     -  
     200,000(3) 
    $5.02(4) 
    $5.26  
    $782,000 
  
    Christopher Chapman, former
    CEO 
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     - 
  
    Nathen Fuentes, former CFO 
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     - 

(1)
The “Grant Date” represents the date on which the Compensation Committee of the Board took action to grant the applicable
award

(2)
The stock awards disclosed in this item consist of options, as issued under our 2023 Omnibus Incentive Plan, which vest 50% at grant
date, and 50% six